UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)            November 7, 2014
 
EBIX, INC.
(Exact name of registrant as specified in its charter)
Delaware
 
0-15946
 
77-0021975
(State or other jurisdiction
 
(Commission File Number)
 
(IRS Employer
of incorporation)
 
 
 
Identification No.)
 
5 Concourse Parkway, Suite 3200, Atlanta, Georgia
 
30328
(Address of principal executive offices)
 
(Zip Code)
 
Registrant's telephone number, including area code     (678) 281-2020
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))























Item 2.02               Results of Operations and Financial Condition.
On November 7, 2014, Ebix, Inc. issued a press release announcing its results of operations for its third fiscal quarter ended September 30, 2014.  A copy of the related press release is being filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.



Item 9.01               Financial Statements and Exhibits.
Exhibits
99.1         Press release, dated November 7, 2014, issued by Ebix, Inc.






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
EBIX, INC.
 
 
 
 
 
By:
/s/ Robert Kerris
 
Name:
Robert Kerris
 
Title:
Chief Financial Officer & Corporate Secretary
 
 
 
 
 
Dated: November 10, 2014





Exhibit 99.1


Ebix Announces THIRD Quarter 2014 Results

ATLANTA, GA - November 7, 2014 - Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, today reported results for the fiscal third quarter ended September 30, 2014.

Ebix delivered the following results for the third quarter of 2014:

Revenues: Total Q3 2014 revenue was $50.8 million, an increase of 1% on a year-over-year basis, as compared to Q3 2013 revenue of $50.3 million.

On a constant currency basis, Q3 2014 revenue increased year over year to $50.5 million as compared to $50.3 million in Q3 of 2013. Also on a constant currency basis, year-to-date revenue increased to $155.8 million as compared to $153.9 million during the same period in 2013.
  
Earnings per Share: Q3 2014 diluted earnings per share of $0.47, an increase of 38% on a year-over-year basis, as compared to Q3 2013 diluted earnings per share of $0.34. For purposes of the Q3 2014 EPS calculation, there was an average of 38.3 million diluted shares outstanding during the quarter, as compared to 38.5 million diluted shares outstanding in Q3 2013.

Q4 2014 Diluted Share Count: As of today, the Company expects the diluted share count for Q4 2014 to be approximately 37.0 million.

Operating Cash: Cash generated from operations in Q3 2014 was $9.8 million, down 25% year over year as compared to $12.9 million in Q3 2013. It was temporarily affected by $11.1 million of cash outflow associated with the payment of income tax, minimum alternate tax, sales tax and certain other prepaids. Before taking the impact of these unique cash outflow items, operating cash flow would have been $20.9 million for the quarter. During the nine months ended September 30, 2014, the Company generated $38.4 million of net cash flow from operating activities, an increase of 2% as compared to $37.8 million in the first nine months of 2013.

Operating Income and Margins: Operating income for Q3 2014 was $21.7 million as compared to $18.6 million of operating income in Q3 2013. Operating margins for Q3 2014 were 43% as compared to 37% for Q3 2013. The operating margins in Q3 2014 were favorably impacted by an amount of $4.4 million, net of a $5.8 million reversal of certain earn out contingent liabilities and certain one time non-recurring expenses of $1.4 million.

Net Income: Q3 2014 net income was $18.0 million, an increase of 37% on a year-over-year basis, as compared to Q3 2013 net income of $13.1 million. During the nine months ended September 30, 2014, net income increased $3.0 million or 7%, to $47.0 million compared to $44.0 million during the same period in 2013.

Channel Revenues: The Exchange channel continued to be the largest channel for Ebix accounting for 82% of the Company’s Q3 2014 revenues.








Exhibit 99.1

(dollar amounts in thousands)
Three Months Ended
September 30,
Nine Months Ended
September 30,
Channel
2014
2013
2014
2013
Exchange
$ 41,757
$ 40,554
$ 125,212
$ 122,741
Broker Systems
4,511
4,390
13,862
13,878
Risk Compliance Solutions (RCS)
3,346
3,604
10,423
11,781
Carrier Systems
1,194
1,745
4,191
5,463
Total Revenue
$ 50,808
$ 50,293
$ 153,688
$ 153,863


The continued strengthening year-over-year of the US dollar, as compared to the Australian dollar and the Brazilian real decreased revenue by $2.1 million during the nine months ended September 30, 2014 across the Exchange and Broker Systems Channels.

Ebix Chairman, President and CEO Robin Raina said, “While the revenues in the third quarter were negatively impacted by the lower transaction count in the Property & Casualty space in the Asia-Pacific region, we had a strong quarter in terms of new deals. We agreed on four key deals with named carriers in the life space, for our TPP system, which we are expecting to begin generating recurring revenues beginning January of 2015. We also signed a recurring subscription based Ebix Enterprise contract with a large health institution. Except for the Asia-Pacific region where our revenue streams temporarily decreased; the life, annuity, reinsurance and health space revenues grew quarter over quarter for the Company.”

“Today we are focused on growing both our top line and earnings and we are better prepared today to make accretive acquisitions while organically growing our business. We are targeting revenues of $250 million to $260 million for 2015.” Robin said, “We intend to continue repurchasing Ebix shares from the open market and believe our share repurchase program coupled with our quarterly dividend is an excellent way to return capital to shareholders while allowing us the ability to make strategic acquisitions.”
 
Robert Kerris, Ebix’s EVP & CFO said, “During the third quarter Ebix used a total of $26 million towards repurchasing its own stock, paying dividends and investing in capital expenditures. After paying for these initiatives, Ebix still had aggregate cash, cash equivalents, and short-term cash deposit investments in the amount of $48.7 million as of September 30, 2014. The Company presently has access to $137 million of additional borrowing capacity on our syndicated senior secured credit facility with Regions Bank. This combined with our available cash balances provides Ebix with ample financial resources to support the continued profitable growth of the Company, organically and through accretive acquisitions, as well as to repurchase shares of our common stock. The Company’s working capital position was $58.7 million and our net debt position stood at $17.7 million at September 30.”

About Ebix, Inc.

A leading international supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, Ebix, Inc., (NASDAQ: EBIX) provides end-to-end solutions ranging from infrastructure exchanges, carrier systems, agency systems and risk compliance solutions to custom software development for all entities involved in the insurance industry.

With 40+ offices across Australia, Brazil, Canada, India, New Zealand, Singapore, the US and the UK, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance. Through its various SaaS-based software platforms, Ebix employs hundreds of insurance and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company’s website at www.ebix.com.

SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS
As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.




Exhibit 99.1

The information contained in this Press Release contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission (“SEC”), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” “should,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.

You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s web site, www.sec.gov.


CONTACT:
Jacqueline Marcus, Edelman - 212-277-3787 or Jacqueline.Marcus@edelman.com
Aaron Tikkoo - 678 -281-2027 or atikkoo@ebix.com













Exhibit 99.1

Ebix, Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30
 
2014
 
2013
 
2014
 
 
2013
 
Operating revenue
$
50,808
 
 
$
50,293
 
 
$
153,688
 
 
$
153,863
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of services provided
10,275
 
 
10,136
 
 
29,851
 
 
30,385
 
Product development
6,779
 
 
6,625
 
 
20,230
 
 
20,384
 
Sales and marketing
3,559
 
 
4,024
 
 
10,644
 
 
11,763
 
General and administrative, net
6,008
 
 
8,448
 
 
26,917
 
 
26,672
 
Amortization and depreciation
2,449
 
 
2,459
 
 
7,442
 
 
7,459
 
Total operating expenses
29,070
 
 
31,692
 
 
95,084
 
 
96,663
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating income
21,738
 
 
18,601
 
 
58,604
 
 
57,200
 
Interest income
61
 
 
159
 
 
326
 
 
343
 
Interest expense
-392
 
 
-318
 
 
-850
 
 
-961
 
Non-operating (loss)/income - put options
-19
 
 
93
 
 
296
 
 
-1,250
 
Non-operating expense - securities litigation
-350
 
 
-4,226
 
 
-350
 
 
-4,226
 
Foreign currency exchange gain (loss)
987
 
 
-33
 
 
532
 
 
-326
 
Income before income taxes
22,025
 
 
14,276
 
 
58,558
 
 
50,780
 
Income tax expense
-4,010
 
 
-1,133
 
 
-11,547
 
 
-6,751
 
Net income
$
18,015
 
 
$
13,143
 
 
$
47,011
 
 
$
44,029
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings per common share
$
0.47
 
 
$
0.35
 
 
$
1.23
 
 
$
1.18
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted earnings per common share
$
0.47
 
 
$
0.34
 
 
$
1.22
 
 
$
1.14
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
38,050
 
 
37,919
 
 
38,264
 
 
37,435
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted weighted average shares outstanding
38,253
 
 
38,451
 
 
38,499
 
 
38,676
 











Exhibit 99.1

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)

 
September 30,
 2014
 
December 31,
 2013
ASSETS
(Unaudited)
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
47,350
 
 
$
56,674
 
Short-term investments
1,326
 
 
801
 
Trade accounts receivable, less allowances of $1,609 and $1,049, respectively
38,361
 
 
39,070
 
Deferred tax asset, net
997
 
 
256
 
Other current assets
6,251
 
 
5,548
 
Total current assets
94,285
 
 
102,349
 
 
 
 
 
 
 
Property and equipment, net
22,648
 
 
8,528
 
Goodwill
350,255
 
 
337,068
 
Intangibles, net
46,504
 
 
50,734
 
Indefinite-lived intangibles
30,887
 
 
30,887
 
Deferred tax asset, net
15,581
 
 
12,194
 
Other assets
4,890
 
 
3,682
 
Total assets
$
565,050
 
 
$
545,442
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable and accrued liabilities
$
11,138
 
 
$
17,818
 
Accrued payroll and related benefits
4,251
 
 
6,482
 
Short term debt
0
 
 
13,062
 
Current portion of long term debt and capital lease obligations, net of discount of $14 and $10, respectively
724
 
 
827
 
Current deferred rent
230
 
 
254
 
Contingent liability for accrued earn-out acquisition consideration
564
 
 
4,137
 
Liability - securities litigation settlement
0
 
 
4,226
 
Put option liability
0
 
 
845
 
Deferred revenue
18,575
 
 
18,918
 
Other current liabilities
84
 
 
106
 
Total current liabilities
35,566
 
 
66,675
 
 
 
 
 
 
 
Revolving line of credit
63,465
 
 
22,840
 
Long term debt and capital lease obligations, less current portion, net of discount of $8 and $38, respectively
898
 
 
20,124
 
Other liabilities
16,473
 
 
4,719
 
Contingent liability for accrued earn-out acquisition consideration
10,286
 
 
10,283
 
Deferred revenue
144
 
 
391
 
Long term deferred rent
1,848
 
 
2,185
 
Total liabilities
128,680
 
 
127,217
 
 
 
 
 
 
 
 
 
 
 
 
 
Temporary equity
0
 
 
5,000
 
 
 
 
 
 
 
Stockholders’ equity:
 
 
 
 
 
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2014 and December 31, 2013
0
 
 
0
 



Exhibit 99.1

Common stock, $0.10 par value, 60,000,000 shares authorized, 37,191,888 issued and 37,151,379 outstanding at September 30, 2014 and 38,088,391 issued and 38,047,882 outstanding at December 31, 2013
3,715
 
 
3,805
 
Additional paid-in capital
151,039
 
 
164,216
 
Treasury stock (40,509 shares as of September 30, 2014 and December 31, 2013)
-76
 
 
-76
 
Retained earnings
295,933
 
 
257,574
 
Accumulated other comprehensive loss
-14,241
 
 
-12,294
 
Total stockholders’ equity
436,370
 
 
413,225
 
Total liabilities and stockholders’ equity
$
565,050
 
 
$
545,442
 




































Exhibit 99.1

Ebix, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
                                                        (In thousands)
Nine Months Ended
                                                         (Unaudited)
September 30,
 
2014
 
2013
Cash flows from operating activities:
 
 
 
 
 
Net income
$
47,011
 
 
$
44,029
 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization
7,442
 
 
7,459
 
Provision (benefit) for deferred taxes
-1,810
 
 
-4,682
 
Share based compensation
1,333
 
 
1,481
 
Provision for doubtful accounts
1,083
 
 
1,361
 
Debt discount amortization on promissory note payable
26
 
 
32
 
Unrealized foreign exchange (gain)
-256
 
 
-94
 
(Gain) loss on put option
-296
 
 
1,250
 
Reduction of acquisition earnout accruals
-7,533
 
 
-10,253
 
Changes in assets and liabilities, net of effects from acquisitions:
 
 
 
 
 
Accounts receivable
-1,901
 
 
-4,562
 
Other assets
-3,977
 
 
845
 
Accounts payable and accrued expenses
-8,064
 
 
-2,568
 
Accrued payroll and related benefits
1,027
 
 
-1,205
 
Deferred revenue
-704
 
 
-2,802
 
Deferred rent
-272
 
 
-60
 
Reserve for potential uncertain income tax return positions
9,337
 
 
3,405
 
Liability - securities litigation settlement payment
-3,868
 
 
4,226
 
Other liabilities
-188
 
 
-86
 
Net cash provided by operating activities
38,390
 
 
37,776
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
Acquisition of Qatarlyst, net of cash acquired
0
 
 
-4,740
 
Acquisition of HealthCare Magic, net of cash acquired
-5,856
 
 
0
 
Acquisition of CurePet, Inc., net of cash acquired
3
 
 
0
 
Payment of acquisition earn-out contingency, Taimma
-2,250
 
 
-2,250
 
Payment of acquisition earn-out contingency, USIX
0
 
 
-727
 
Maturities of marketable securities
0
 
 
104
 
Purchases of marketable securities
-595
 
 
0
 
Capital expenditures
-15,922
 
 
-887
 
Net cash used in investing activities
-24,620
 
 
-8,500
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
Proceeds from / (Repayments) on revolving line of credit, net
40,625
 
 
-15,000
 
Principal payments of term loan obligation
-31,938
 
 
-6,531
 
Repurchases of common stock
-16,482
 
 
-2,492
 
Excess tax benefit from share-based compensation
-3,200
 
 
0
 
Proceeds from the exercise of stock options
788
 
 
1,425
 
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested
-37
 
 
-916
 
Dividend payments
-8,652
 
 
-2,794
 
Shares reacquired in connection with put option
-3,535
 
 
0
 
Principal payments of debt obligations
-336
 
 
-636
 
Payments of capital lease obligations
-144
 
 
-221
 
Net cash used in financing activities
-22,911
 
 
-27,165
 
Effect of foreign exchange rates on cash
-183
 
 
-1,671
 
Net change in cash and cash equivalents
-9,324
 
 
440
 
Cash and cash equivalents at the beginning of the period
56,674
 
 
36,449
 
Cash and cash equivalents at the end of the period
$
47,350
 
 
$
36,889
 
Supplemental disclosures of cash flow information:
 
 
 
 
 
Interest paid
$
849
 
 
$
901
 
Income taxes paid
$
10,782
 
 
$
13,009
 


Ebix (NASDAQ:EBIX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ebix Charts.
Ebix (NASDAQ:EBIX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ebix Charts.